Majdi Al-Hasan to Female
This is a "connection" page, showing publications Majdi Al-Hasan has written about Female.
Connection Strength
0.831
-
Clostridioides difficile infection and antibiotic prescription rates in the community: Explaining the gender gap. Infect Control Hosp Epidemiol. 2021 05; 42(5):622-624.
Score: 0.039
-
Use of Antibiotics in Chronic Obstructive Pulmonary Disease: What is Their Current Role in Older Patients? Drugs Aging. 2020 09; 37(9):627-633.
Score: 0.038
-
Temporal trends in ambulatory antibiotic prescription rates in South Carolina: Impact of age, gender, and resident location. Infect Control Hosp Epidemiol. 2020 08; 41(8):879-882.
Score: 0.037
-
Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. J Glob Antimicrob Resist. 2020 09; 22:87-93.
Score: 0.036
-
Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study. Infection. 2020 Feb; 48(1):129-132.
Score: 0.036
-
Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections. Clin Infect Dis. 2019 07 18; 69(3):414-420.
Score: 0.035
-
Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7.
Score: 0.034
-
Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection. Infection. 2019 Aug; 47(4):571-578.
Score: 0.034
-
Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018 Aug; 46(4):487-494.
Score: 0.032
-
Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Pharmacotherapy. 2018 01; 38(1):42-50.
Score: 0.031
-
Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
Score: 0.031
-
Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
Score: 0.030
-
Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5).
Score: 0.030
-
Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
Score: 0.029
-
Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304.
Score: 0.029
-
Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91.
Score: 0.029
-
Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503.
Score: 0.029
-
Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control. 2016 12 01; 44(12):1611-1616.
Score: 0.029
-
Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
Score: 0.028
-
Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015 Jan; 59(1):245-50.
Score: 0.025
-
Impact of Gram-negative bloodstream infection on long-term allograft survival after kidney transplantation. Transplantation. 2011 Jun 15; 91(11):1206-10.
Score: 0.020
-
Cefepime effectiveness in Gram-negative bloodstream infections. J Antimicrob Chemother. 2011 May; 66(5):1156-60.
Score: 0.020
-
Recurrent gram-negative bloodstream infection: a 10-year population-based cohort study. J Infect. 2010 Jul; 61(1):28-33.
Score: 0.018
-
Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clin Proc. 2010 Feb; 85(2):139-44.
Score: 0.018
-
Bacteremia complicating gram-negative urinary tract infections: a population-based study. J Infect. 2010 Apr; 60(4):278-85.
Score: 0.018
-
Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother. 2009 Jul; 64(1):169-74.
Score: 0.017
-
Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother. 2009 Apr; 53(4):1386-94.
Score: 0.017
-
Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med. 2008 Aug; 121(8):702-8.
Score: 0.016
-
Invasive enteric infections in hospitalized patients with underlying strongyloidiasis. Am J Clin Pathol. 2007 Oct; 128(4):622-7.
Score: 0.015
-
Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infections. J Glob Antimicrob Resist. 2020 06; 21:218-222.
Score: 0.009
-
Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters - the role of sickle cell anaemia. Infect Dis (Lond). 2017 May; 49(5):341-346.
Score: 0.007
-
Comparison of ?-lactam plus aminoglycoside versus ?-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli. J Chemother. 2017 Feb; 29(1):30-37.
Score: 0.007
-
Temporal trends, clinical characteristics, and outcomes of histoplasmosis in a tertiary care center in Kentucky, 2000 to 2009. J Int Assoc Provid AIDS Care. 2014 Mar-Apr; 13(2):100-5.
Score: 0.006